Non-Cystic Fibrosis Bronchiectasis Market - Global Outlook and Forecast 2021-2027

April 2021 | 94 pages | ID: N2676A074C47EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Non-Cystic Fibrosis Bronchiectasis in Global, including the following market information:

Global Non-Cystic Fibrosis Bronchiectasis Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Non-Cystic Fibrosis Bronchiectasis market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Cystic Fibrosis Bronchiectasis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-Cystic Fibrosis Bronchiectasis Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Non-Cystic Fibrosis Bronchiectasis Market Segment Percentages, By Type, 2020 (%)

• Oral
• Intravenous

China Non-Cystic Fibrosis Bronchiectasis Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Non-Cystic Fibrosis Bronchiectasis Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Others

Global Non-Cystic Fibrosis Bronchiectasis Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Non-Cystic Fibrosis Bronchiectasis Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Non-Cystic Fibrosis Bronchiectasis Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Non-Cystic Fibrosis Bronchiectasis Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Aradigm Corporation
• Zambon
• Novartis Pharmaceuticals
• Insmed Incorporated

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bronchiolitis Obliterans Syndrome Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bronchiolitis Obliterans Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME OVERALL MARKET SIZE

2.1 Global Bronchiolitis Obliterans Syndrome Market Size: 2021 VS 2027
2.2 Global Bronchiolitis Obliterans Syndrome Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bronchiolitis Obliterans Syndrome Players in Global Market
3.2 Top Global Bronchiolitis Obliterans Syndrome Companies Ranked by Revenue
3.3 Global Bronchiolitis Obliterans Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Bronchiolitis Obliterans Syndrome Companies in Global Market, by Revenue in 2020
3.5 Global Companies Bronchiolitis Obliterans Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bronchiolitis Obliterans Syndrome Players in Global Market
  3.6.1 List of Global Tier 1 Bronchiolitis Obliterans Syndrome Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bronchiolitis Obliterans Syndrome Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Bronchiolitis Obliterans Syndrome Market Size Markets, 2021 & 2027
  4.1.2 Inhalation
  4.1.3 Oral
4.2 By Type - Global Bronchiolitis Obliterans Syndrome Revenue & Forecasts
  4.2.1 By Type - Global Bronchiolitis Obliterans Syndrome Revenue, 2016-2021
  4.2.2 By Type - Global Bronchiolitis Obliterans Syndrome Revenue, 2022-2027
  4.2.3 By Type - Global Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bronchiolitis Obliterans Syndrome Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Bronchiolitis Obliterans Syndrome Revenue & Forecasts
  5.2.1 By Application - Global Bronchiolitis Obliterans Syndrome Revenue, 2016-2021
  5.2.2 By Application - Global Bronchiolitis Obliterans Syndrome Revenue, 2022-2027
  5.2.3 By Application - Global Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Bronchiolitis Obliterans Syndrome Market Size, 2021 & 2027
6.2 By Region - Global Bronchiolitis Obliterans Syndrome Revenue & Forecasts
  6.2.1 By Region - Global Bronchiolitis Obliterans Syndrome Revenue, 2016-2021
  6.2.2 By Region - Global Bronchiolitis Obliterans Syndrome Revenue, 2022-2027
  6.2.3 By Region - Global Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Bronchiolitis Obliterans Syndrome Revenue, 2016-2027
  6.3.2 US Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.3.3 Canada Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.3.4 Mexico Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Bronchiolitis Obliterans Syndrome Revenue, 2016-2027
  6.4.2 Germany Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.4.3 France Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.4.4 U.K. Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.4.5 Italy Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.4.6 Russia Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.4.7 Nordic Countries Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.4.8 Benelux Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Bronchiolitis Obliterans Syndrome Revenue, 2016-2027
  6.5.2 China Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.5.3 Japan Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.5.4 South Korea Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.5.5 Southeast Asia Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.5.6 India Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Bronchiolitis Obliterans Syndrome Revenue, 2016-2027
  6.6.2 Brazil Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.6.3 Argentina Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bronchiolitis Obliterans Syndrome Revenue, 2016-2027
  6.7.2 Turkey Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.7.3 Israel Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.7.4 Saudi Arabia Bronchiolitis Obliterans Syndrome Market Size, 2016-2027
  6.7.5 UAE Bronchiolitis Obliterans Syndrome Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Breath Therapeutics
  7.1.1 Breath Therapeutics Corporate Summary
  7.1.2 Breath Therapeutics Business Overview
  7.1.3 Breath Therapeutics Bronchiolitis Obliterans Syndrome Major Product Offerings
  7.1.4 Breath Therapeutics Bronchiolitis Obliterans Syndrome Revenue in Global (2016-2021)
  7.1.5 Breath Therapeutics Key News
7.2 Genentech
  7.2.1 Genentech Corporate Summary
  7.2.2 Genentech Business Overview
  7.2.3 Genentech Bronchiolitis Obliterans Syndrome Major Product Offerings
  7.2.4 Genentech Bronchiolitis Obliterans Syndrome Revenue in Global (2016-2021)
  7.2.5 Genentech Key News
7.3 Incyte Corporation
  7.3.1 Incyte Corporation Corporate Summary
  7.3.2 Incyte Corporation Business Overview
  7.3.3 Incyte Corporation Bronchiolitis Obliterans Syndrome Major Product Offerings
  7.3.4 Incyte Corporation Bronchiolitis Obliterans Syndrome Revenue in Global (2016-2021)
  7.3.5 Incyte Corporation Key News
7.4 Mereo BioPharma
  7.4.1 Mereo BioPharma Corporate Summary
  7.4.2 Mereo BioPharma Business Overview
  7.4.3 Mereo BioPharma Bronchiolitis Obliterans Syndrome Major Product Offerings
  7.4.4 Mereo BioPharma Bronchiolitis Obliterans Syndrome Revenue in Global (2016-2021)
  7.4.5 Mereo BioPharma Key News
7.5 Altavant Sciences
  7.5.1 Altavant Sciences Corporate Summary
  7.5.2 Altavant Sciences Business Overview
  7.5.3 Altavant Sciences Bronchiolitis Obliterans Syndrome Major Product Offerings
  7.5.4 Altavant Sciences Bronchiolitis Obliterans Syndrome Revenue in Global (2016-2021)
  7.5.5 Altavant Sciences Key News
7.6 Koutif Therapeutics
  7.6.1 Koutif Therapeutics Corporate Summary
  7.6.2 Koutif Therapeutics Business Overview
  7.6.3 Koutif Therapeutics Bronchiolitis Obliterans Syndrome Major Product Offerings
  7.6.4 Koutif Therapeutics Bronchiolitis Obliterans Syndrome Revenue in Global (2016-2021)
  7.6.5 Koutif Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Non-Cystic Fibrosis Bronchiectasis Market Opportunities & Trends in Global Market
Table 2. Non-Cystic Fibrosis Bronchiectasis Market Drivers in Global Market
Table 3. Non-Cystic Fibrosis Bronchiectasis Market Restraints in Global Market
Table 4. Key Players of Non-Cystic Fibrosis Bronchiectasis in Global Market
Table 5. Top Non-Cystic Fibrosis Bronchiectasis Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Non-Cystic Fibrosis Bronchiectasis Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Non-Cystic Fibrosis Bronchiectasis Revenue Share by Companies, 2016-2021
Table 8. Global Companies Non-Cystic Fibrosis Bronchiectasis Product Type
Table 9. List of Global Tier 1 Non-Cystic Fibrosis Bronchiectasis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Cystic Fibrosis Bronchiectasis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Non-Cystic Fibrosis Bronchiectasis Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Non-Cystic Fibrosis Bronchiectasis Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Non-Cystic Fibrosis Bronchiectasis Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Non-Cystic Fibrosis Bronchiectasis Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Non-Cystic Fibrosis Bronchiectasis Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Non-Cystic Fibrosis Bronchiectasis Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2022-2027
Table 30. Aradigm Corporation Corporate Summary
Table 31. Aradigm Corporation Non-Cystic Fibrosis Bronchiectasis Product Offerings
Table 32. Aradigm Corporation Non-Cystic Fibrosis Bronchiectasis Revenue (US$, Mn), (2016-2021)
Table 33. Zambon Corporate Summary
Table 34. Zambon Non-Cystic Fibrosis Bronchiectasis Product Offerings
Table 35. Zambon Non-Cystic Fibrosis Bronchiectasis Revenue (US$, Mn), (2016-2021)
Table 36. Novartis Pharmaceuticals Corporate Summary
Table 37. Novartis Pharmaceuticals Non-Cystic Fibrosis Bronchiectasis Product Offerings
Table 38. Novartis Pharmaceuticals Non-Cystic Fibrosis Bronchiectasis Revenue (US$, Mn), (2016-2021)
Table 39. Insmed Incorporated Corporate Summary
Table 40. Insmed Incorporated Non-Cystic Fibrosis Bronchiectasis Product Offerings
Table 41. Insmed Incorporated Non-Cystic Fibrosis Bronchiectasis Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Non-Cystic Fibrosis Bronchiectasis Segment by Type
Figure 2. Non-Cystic Fibrosis Bronchiectasis Segment by Application
Figure 3. Global Non-Cystic Fibrosis Bronchiectasis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Non-Cystic Fibrosis Bronchiectasis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Non-Cystic Fibrosis Bronchiectasis Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Cystic Fibrosis Bronchiectasis Revenue in 2020
Figure 8. By Type - Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share, 2016-2027
Figure 9. By Application - Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share, 2016-2027
Figure 10. By Region - Global Non-Cystic Fibrosis Bronchiectasis Revenue Market Share, 2016-2027
Figure 11. By Country - North America Non-Cystic Fibrosis Bronchiectasis Revenue Market Share, 2016-2027
Figure 12. US Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Non-Cystic Fibrosis Bronchiectasis Revenue Market Share, 2016-2027
Figure 16. Germany Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 17. France Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Non-Cystic Fibrosis Bronchiectasis Revenue Market Share, 2016-2027
Figure 24. China Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 28. India Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Non-Cystic Fibrosis Bronchiectasis Revenue Market Share, 2016-2027
Figure 30. Brazil Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Non-Cystic Fibrosis Bronchiectasis Revenue Market Share, 2016-2027
Figure 33. Turkey Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Non-Cystic Fibrosis Bronchiectasis Revenue, (US$, Mn), 2016-2027
Figure 37. Aradigm Corporation Non-Cystic Fibrosis Bronchiectasis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Zambon Non-Cystic Fibrosis Bronchiectasis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis Pharmaceuticals Non-Cystic Fibrosis Bronchiectasis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)